Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to UPM's press conference and webcast on Interim Results for the first quarter of 2016

(UPM, Helsinki, 19 April 2016 at 10:00 EET) - UPM will publish its first quarter 2016 results on 26 April 2016 at 09:30-10:00 EET. The report will be available on the company's website at www.upm.com  after publishing. UPM's President and CEO Jussi Pesonen will present the results in a webcast and a conference call for analysts and investors, held in English language, on 26 April 2016 at 13:15 EET. Later in the afternoon, Jussi Pesonen will present the results in a press conference held in Finnish language at the UPM Group Head Office (The

Stillfront Group AB: Stillfront Publishes 2015 Annual Report

PRESS RELEASEApril 19, 2016 Stillfront Publishes 2015 Annual Report Stillfront Group AB (publ) is today publishing its Annual Report for 2015. The report is available at Stillfront's web site www.stillfront.com/site/investor-relations/financial-reports . The year in summary: · Net revenues amounted to 57.1 MSEK (29.1 MSEK) · Underlying EBITDA, i.e. EBITDA adjusted for expensed investments, amounted to 12.9 MSEK (2.3 MSEK).  EBITDA amounted to 4.0 MSEK (-8.2 MSEK) · Profit/loss before tax was -4.5 MSEK (-23.8 MSEK). Profit/loss after tax was -6.3 MSEK (-23.8 MSEK) ·

Induct  – Completion of private placements of NOK 18 million – update on subscription period in subsequent offering of NOK 5 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES.Oslo, Norway – 19 April 2016 Reference is made to the stock exchange notices published on 7 April 2016, 11 April 2016, 12 April 2016 and 18 April 2016 regarding inter alia two private placements with gross proceeds of NOK 18 million (of which NOK 9 million has been raised in cash and NOK 9 million through conversion of debt) and a subsequent offering to eligible shareholders. An extraordinary general meeting in Induct AS ("Induct" or the "Company")

Episurf Medical receives expanded reimbursement coverage in the UK, Netherlands and Belgium

In line with Episurf Medical’s plan to achieve private health sector reimbursement, the Episealer® procedure and products have been approved for payment in the UK Spire Hospitals and the Dutch health insurance companies, VGZ and Multiorg. This means that surgeons wishing to perform the Episealer® procedure are approved to operate and the procedure and devices will be paid for. Further, the Belgium reimbursement authority RIZIV – The National Institute for Health and Disability Insurance - has approved the Episealer® Femoral Twin implant. This means the entire Episealer® Portfolio

A lifelong home

YIT CORPORATION News, April 19, 2016 at 9:45 a.m.In Finland, most people prefer to live in their own home for as long as possible. It is also the best alternative from the perspective of the national economy. To reach this goal, we need new housing solutions. Citizens over 65 years old are hardly a uniform group. The group is called by many different names, which is one sign of the diversity of its members.“We talk about senior citizens, the elderly, the aged, or the older generation. And we all have a different idea of what these words mean,” states Mikko Lempinen, YIT Property

Fasten seatbelts, ready for take-off!

BizView welcomes OSM Aviation to the increasing pool of businesses that have chosen BizView as their main CPM tool. Our reputation is growing, and we are seated safely for a huge take-off! Disruptive industry solutions OSM Aviation is responsible for manning a huge number of daily flights in and out of Europe, and the demand for flexible and powerful guiding tools are obvious. "Global growth companies within low margin service sectors are really in need of strong tools for financial management and planning," says CFO Stig Storm-Hansen at OSM Aviation. "With BizView we now have a

Senzime receives research grant from Bio-X

Uppsala, April 19, 2016. Senzime receives research grant from Vinnova through Bio-X, to conduct a study designed for clinical evaluation of OnZurf Probe and CliniSenz Analyzer for postoperative monitoring of patients with esophagus cancer. The grant also provides the ability to carry out activities prior to commercialization and CE marking of the products. The grant amounts to SEK 2 million, and the study will be conducted in Lund."Through blood tests, for example, lack of oxygen in the newly operated organ in some cases is detected after several days. Coupled with OnZurf Probe, our

A stable start of 2016

First quarter · Turnover MSEK 260.6 (256.4), up 2 percent compared to previous year · Operating profit MSEK 7.1 (10.1), non recurring start-up costs of MSEK 3.0 (0.0) in the new facility PG&WIP has affected the result negatively · Net income MSEK 4.8 (6.7) · Cash flow from operating activities MSEK 1.4 (-9.9) · Earnings per share SEK 0.78 (0.91) Per Thorsell, CEO of ProfilGruppen, comments: ”The year has had a stable start. Our work to improve all areas of the business is in full progress and we can see the effects in our production efficiency as well as in how we

Annual General Meeting of Endomines AB (publ) on 18 April 2016

The Annual General Meeting (the “AGM”) of shareholders of Endomines AB (publ) was held on 18 April 2016.Appropriation of Endomines AB’s (publ) loss and discharge from liability for members of the Board of Directors and the CEOThe AGM resolved to adopt the Profit and Loss Statement and the Balance Sheet for the parent company as well as the Consolidated Profit and Loss Statement and the Consolidated Balance Sheet for the Group for 2015. The AGM resolved that no dividend should be paid and that the company’s result should be disposed so that SEK 1,319,895 shall be carried forward. The

Interim report, January - March 2016

Period January 1 – March 31, 2016 · Net sales SEK 87,3.1 m (SEK 84.3 m) · System revenue SEK 58.1 m (SEK 57.1 m) · Recurring revenue, percentage of net sales 51% (50%) · EBITDA SEK 16.4 m (SEK 18.6 m) · EBITDA margin 18.8% (22.0%) · EBIT SEK 2.8 m (SEK 5.9 m) · Net profit SEK 1.4 m (SEK 2.2 m) · EPS before dilution SEK 0.02 (SEK 0.04) · Cash flow from operating activities SEK 12.2 m (SEK 14.4 m) For additional information, contact:Christian Sundin, President and CEO of Formpipe, +46 705 67 73 85 For the full report, see attached PDF. __________________

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING

The shareholders of Qliro Group AB (publ) are hereby invited to the Annual General Meeting of shareholders on Monday 23 May 2016 at 3.00 p.m. at Hotel Rival, Mariatorget 3 in Stockholm.NOTICE ETC.Shareholders who wish to attend the Annual General Meeting shall · be entered in the share register maintained by Euroclear Sweden on Tuesday 17 May 2016, · give notice of their attendance no later than Tuesday 17 May 2016, preferably before 1.00 p.m. CET. Notice to attend is to be made on the company's website at www.qlirogroup.com, by telephone to +46 (0) 771 246 400 or by mail to

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING

The shareholders of Tele2 AB (publ) are hereby invited to the Annual General Meeting on Tuesday 24 May 2016 at 10.00 a.m. CET at the Hotel Rival, Mariatorget 3 in Stockholm.NOTICE ETC. Shareholders who wish to attend the Annual General Meeting shall · be entered in the share register maintained by Euroclear Sweden on Wednesday 18 May 2016, · give notice of their attendance no later than Wednesday 18 May 2016, preferably before 1.00 p.m. CET. Notice to attend is to be made on the company's website at www.tele2.com, by telephone to +46 (0) 771 246 400 or by mail to Computershare AB

Payair signs contract with Eika Gruppen AS

Payair Technologies AB has signed a contract with Eika Gruppen AS to build their Masterpass digital wallet. The wallet will be launched during autumn 2016. Masterpass is developed by Mastercard and makes it possible to pay anytime from smartphones, computers and tablets, and with all types of cards. Card- and shipping information are stored comfortably and securely in Masterpass.The Eika Alliance comprises the Eika Banks, Eika Gruppen and Eika Boligkreditt. It ranks as one of the largest players in the Norwegian financial market, with a total assets of NOK 300 billion and almost a

Rottneros Board raises the proposed dividend for 2015

The Board of Rottneros AB (publ) has decided to increase the dividend proposal and propose to the Annual General Meeting a dividend of 0,30 SEK per share and an extra dividend of 0,20 SEK per share, i.e. a total dividend of 0,50 SEK per share.The Board has previously proposed an ordinary dividend of 0,30 SEK per share, announced in the year-end report for 2015, published February 12, 2016, and in the profit allocation proposal in the Annual Report for 2015, published March 21, 2016. The background of the increased proposal is the positive development of the Group during the past two

Cxense Signs Agreement with Le Télégramme

Oslo, Norway – 19 April 2016 – Cxense ASA  (OSE: CXENSE) today announced that Le Télégramme  has signed an agreement with Cxense, which includes licensing for the Cxense DMP, Insight, and Content products. Le Télégramme is a leading French language news publication in Brittany, France, founded by members of the French Resistance in September 1944. This newspaper covers local and regional politics, entertainment, media, health, culture, sports, and business news. The paper is currently distributed in Finistère, les Côtes-d'Armor and

Notice of Annual General Meeting in Moberg Pharma AB (publ)

Shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Monday, May 18, 2016 at 5:00 p.m. (CET) in the Company´s premises in Bromma, address Gustavslundsvägen 42, 5 tr, 167 51 Bromma (Alviks torg), Sweden. To celebrate Moberg Pharma’s 10 year anniversary, shareholders are invited to a cocktail reception directly after the AGM, i.e. approximately at 6:00 p.m. Welcome!Attendance at the Annual General MeetingShareholders who wish to participate in the Annual General Meeting must:-       be recorded in the share

WELCOME TO ANNUAL GENERAL MEETING (AGM) IN OPUS GROUP AB (PUBL)

Shareholders of Opus Group AB (publ) are hereby notified of the Annual General Meeting (AGM) to be held on Thursday, May 19, 2016, at 18.00, local time, at the Elite Park Avenue Hotel, Kungsportsavenyn 36-38, Gothenburg, Sweden. Registration for the AGM takes place from 17:00.NOTICE OF PARTICIPATION Shareholders wishing to participate in the AGM shall be registered in the Shareholders’ Register held by Euroclear Sweden AB as of Friday May 13, 2016, and have notified the company of their intention to attend by Friday May 13, 2016. Notification of participation at the AGM shall be made

Tele2 AB: Nomination Committee proposals regarding election of Board of Directors

In advance of the Tele2 AB (publ) (“Tele2”) Annual General Meeting of shareholders to be held on Tuesday 24 May 2016, the Tele2 Nomination Committee proposes the re-election of Mike Parton, Lorenzo Grabau, Irina Hemmers, Eamonn O’Hare and Carla Smits-Nusteling as Directors of the Board, and the election of Sofia Arhall Bergendorff, Georgi Ganev and Cynthia Gordon as new Directors of the Board. The Nomination Committee also proposes the re-election of Mike Parton as Chairman of the Board of Directors. Erik Mitteregger has decided not to seek re-election.Sofia Arhall Bergendorff is Director

The Nomination Committee's proposal for the Board of Directors of Qliro Group

In advance of the Annual General Meeting of shareholders in Qliro Group AB (publ) to be held on May 23, 2016, the Nomination Committee proposes the re-election of current Board members Lars-Johan Jarnheimer, Patrick Andersen, Lorenzo Grabau, David Kelly, Daniel Mytnik and Peter Sjunnesson. The Committee also proposes the election of Caren Genthner-Kappesz as new Board member. Furthermore, the Nomination Committee proposes the re-election of Lars-Johan Jarnheimer as Chairman of the Board. Current Board members Mengmeng Du and Jens Grede have declined re-election.Caren Genthner-Kappesz is the

The MTG Nomination Committee’s proposal for Board of Directors

In advance of the Modern Times Group MTG AB (publ) (“MTG”) Annual General Meeting to be held on Tuesday 24 May 2016, the MTG Nomination Committee proposes the re-election of David Chance, Joakim Andersson, Simon Duffy and Bart Swanson as Directors of the Board, and the election of Donata Hopfen and John Lagerling as new Directors of the Board. The Nomination Committee also proposes the re-election of David Chance as Chairman of the Board. Michelle Guthrie and Alexander Izosimov have decided not to seek re-election.Donata Hopfen is the Publishing Director and Head of the Management Board of

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING

The shareholders of Modern Times Group MTG AB (publ) are hereby invited to the Annual General Meeting on Tuesday 24 May 2016 at 3.00 p.m. CET at the Hotel Rival, Mariatorget 3 in Stockholm.NOTICE TO ATTEND ETC. Shareholders who wish to attend the Annual General Meeting shall · be entered in the share register maintained by Euroclear Sweden on Wednesday 18 May 2016; and · give notice of their attendance no later than Wednesday 18 May 2016, preferably before 1.00 p.m. CET. Notification is to be made on the company's website at www.mtg.com, by telephone to +46 (0) 771 246 400 or by

Patient recruitment completed in Phase II clinical study with IdeS in kidney transplantation

Hansa Medical AB (publ) today announced that the last patient, in the ongoing Phase II study at Uppsala University Hospital and Karolinska University Hospital in Huddinge, has been treated with IdeS and subsequently transplanted.Highlights about the Phase II Clinical Study: · Recruitment completed with 10 patients included. · All 10 patients have been transplanted following treatment with IdeS. · The Phase II clinical study is a single arm, open label study. · The study primarily evaluates safety and tolerability of the candidate drug IdeS in sensitized kidney transplantation

NOTE’s Interim Report January–March 2016

Financial performance January–March• Sales increased by 1% to SEK 279.1 (275.3) million.• Operating profit increased to SEK 14.2 (11.9) million.• Operating margin expanded by 0.8 percentage points to 5.1% (4.3%).• Profit after financial items increased to SEK 12.9 (11.0) million.• Profit after tax increased to SEK 10.2 (9.3) million, corresponding to SEK 0.35 (0.32) per share.• Cash flow after investments increased to SEK 27.1 (21.8) million, or SEK 0.94 (0.76) per share.CEO’s comment”NOTE is one of the most competitive electronics manufacturers in the Nordics. In the first

There are no items matching the current filter
There are no more items matching the current filter
Back to top